Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) Cash & Equivalents Growth (3y) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -9.44%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 19.87%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -36.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 36.60%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 40.99%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 34.11%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.52%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -0.70%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.25%
10 Xtant Medical Holdings 64.46 Mn 47.14 Mn 17.75 Mn -5.64%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -5.64%
Sep 30, 2025 -15.70%
Jun 30, 2025 -25.13%
Mar 31, 2025 -33.16%
Dec 31, 2024 -30.22%
Sep 30, 2024 -28.67%
Jun 30, 2024 -35.78%
Mar 31, 2024 -37.52%
Dec 31, 2023 34.65%
Sep 30, 2023 46.76%
Jun 30, 2023 11.08%
Mar 31, 2023 16.91%
Dec 31, 2022 57.08%
Sep 30, 2022 44.55%
Jun 30, 2022 31.12%
Mar 31, 2022 33.40%
Dec 31, 2021 38.97%
Sep 30, 2021 53.11%
Jun 30, 2021 49.75%
Mar 31, 2021 44.55%
Dec 31, 2020 -6.41%
Sep 30, 2020 9.83%
Jun 30, 2020 21.94%
Mar 31, 2020 9.21%
Dec 31, 2019 26.65%
Sep 30, 2019 59.81%
Jun 30, 2019 48.88%
Mar 31, 2019 14.98%
Dec 31, 2018 2.20%
Sep 30, 2018 -14.03%
Jun 30, 2018 43.99%
Mar 31, 2018 28.64%
Dec 31, 2017 -13.86%
Sep 30, 2017 -33.24%
Jun 30, 2017 -17.72%
Mar 31, 2017 -19.51%
Dec 31, 2016 -5.41%
Sep 30, 2016 -25.72%
Jun 30, 2016 -24.42%
Mar 31, 2016 30.12%
Dec 31, 2015 8.94%
Sep 30, 2015 -2.56%
Jun 30, 2015 18.63%
Mar 31, 2015 28.59%
Dec 31, 2014 81.19%
Sep 30, 2014 56.48%
Jun 30, 2014 28.70%
Mar 31, 2014 133.32%
Dec 31, 2013 110.31%
Sep 30, 2013 81.83%
Jun 30, 2013 17.98%